Adage Capital Partners’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
2023
Q1
$477K Hold
2022
Q4
$438K Hold
2022
Q3
$1.28M Sell
2022
Q2
$1.82M Buy
2022
Q1
$1.21M Buy
2018
Q4
Sell
2018
Q3
$200K Hold
2018
Q2
$212K Hold
2018
Q1
$272K Buy
2015
Q1
Sell
2014
Q4
$1.99M Buy
2014
Q1
Sell
2013
Q4
$178K Buy
2013
Q3
Sell
2013
Q2
$778K Buy